Domestic division of Eli Lilly plans major lay-offs

According to the firm's employees, around 40% of the 320 strong workforce could lose their jobs. Anna Kozerska, the corporate director of Eli Lilly, ensures that the number and the names of the people who will be laid off will be the result of negotiations, which could take up to 20 days. Company representatives claim that the reason for such a move is a predicted fall in turnover on the domestic market. This is due to the Health Ministry's decision to replace Eli Lilly's product with a domestic equivalent drug on the list of refunded pharmaceuticals. The company has estimated that this decision will lead to a decrease in domestic turnover by almost 40%. Anna Kozerska emphasized that the situation in Poland regarding new pharmaceutical products is worsening and did not fulfill the company's expectations. (Puls Biznesu, p. 8) A.K.